ORAL METOCLOPRAMIDE WITH OR WITHOUT DIPHENHYDRAMINE - POTENTIAL FOR PREVENTION OF LATE NAUSEA AND VOMITING INDUCED BY CISPLATIN

被引：33

作者：

GRUNBERG, SM

EHLER, E

MCDERMED, JE

AKERLEY, WL

机构：

[1] UNIV SO CALIF,LOS ANGELES CTY MED CTR,LOS ANGELES,CA 90033

[2] UNIV SO CALIF,DEPT CLIN PHARM,LOS ANGELES,CA 90089

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1988年 / 80卷 / 11期

关键词：

D O I：

10.1093/jnci/80.11.864

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：864 / 868

页数：5

共 16 条

[1]

HIGH-DOSE ORAL METOCLOPRAMIDE - AN EFFECTIVE ANTIEMETIC AGENT [J].

ALAVI, JB ;

TORRI, S ;

GLOVER, D ;

HURWITZ, S ;

GLICK, JH .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1985, 8 (03) :260-265

[2]

ANTIEMETIC EFFECT OF ORAL VERSUS INTRAVENOUS METOCLOPRAMIDE IN PATIENTS RECEIVING CISPLATIN - A RANDOMIZED, DOUBLE-BLIND TRIAL [J].

ANTHONY, LB ;

KROZELY, MG ;

WOODWARD, NJ ;

HAINSWORTH, JD ;

HANDE, KR ;

BRENNER, DE ;

GRECO, FA ;

BURISH, TG .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (01) :98-103

[3]

PATIENT ADHERENCE TO PRESCRIBED THERAPIES [J].

BECKER, MH .

MEDICAL CARE, 1985, 23 (05) :539-555

[4]

CLARK R, 1986, Proceedings American Society of Clinical Oncology Annual Meeting, V5, P257

[5]

COMPARISON OF THE ANTIEMETIC EFFECT OF HIGH-DOSE INTRAVENOUS METOCLOPRAMIDE AND HIGH-DOSE INTRAVENOUS HALOPERIDOL IN A RANDOMIZED DOUBLE-BLIND CROSSOVER STUDY [J].

GRUNBERG, SM ;

GALA, KV ;

LAMPENFELD, M ;

JAMIN, D ;

JOHNSON, K ;

CARIFFE, P ;

STRYCH, D ;

KRAILO, M .

JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (07) :782-787

[6]

COMPARISON OF METOCLOPRAMIDE AND METOCLOPRAMIDE PLUS DEXAMETHASONE FOR COMPLETE PROTECTION FROM CISPLATINUM-INDUCED EMESIS [J].

GRUNBERG, SM ;

AKERLEY, WL ;

KRAILO, MD ;

JOHNSON, KB ;

BAKER, CR ;

CARIFFE, PA .

CANCER INVESTIGATION, 1986, 4 (05) :379-385

[7]

INCIDENCE, COURSE, AND SEVERITY OF DELAYED NAUSEA AND VOMITING FOLLOWING THE ADMINISTRATION OF HIGH-DOSE CISPLATIN [J].

KRIS, MG ;

GRALLA, RJ ;

CLARK, RA ;

TYSON, LB ;

OCONNELL, JP ;

WERTHEIM, MS ;

KELSEN, DP .

JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (10) :1379-1384

[8]

MASON BA, 1982, CANCER TREAT REP, V66, P243

[9]

Sackett DL, 1979, COMPLIANCE HLTH CARE

[10]

EFFECTIVE CONTROL OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING WITH ORAL PREDNISONE AND METOCLOPRAMIDE [J].

SENN, HJ ;

GLAUS, A ;

BACHMANNMETTLER, I .

JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (04) :320-322

← 1 2 →